Bactiguard Holding AB's EBIT per Share for the
three
months ended in Mar. 2026 was kr-0.17.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.15.
During the past 3 years, the average EBIT per Share Growth Rate was 48.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 13.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Bactiguard Holding AB's EBIT per Share or its related term are showing as below:
CHIX:BACTBs'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -218 Med: 11.1 Max: 87.1
Current: 48.2
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Bactiguard Holding AB was 87.10% per year. The lowest was -218.00% per year. And the median was 11.10% per year.
CHIX:BACTBs's 3-Year EBIT Growth Rate is ranked better than 88.84% of 690
companies
in the Medical Devices & Instruments industry
Industry Median: 9.5
vs CHIX:BACTBs: 48.20
Bactiguard Holding AB (CHIX:BACTBs) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Bactiguard Holding AB EBIT per Share Related Terms
Bactiguard Holding AB EBIT per Share Historical Data
* Premium members only.
The historical data trend for Bactiguard Holding AB's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.15
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bactiguard Holding AB (CHIX:BACTBS) has a EBIT per Share of kr-0.15 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Bactiguard Holding AB and its competitors. According to the industry distribution chart, Bactiguard Holding AB ranks #77 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 11.2%.
Is Bactiguard Holding AB's EBIT per Share too high?
Bactiguard Holding AB's current EBIT per Share is kr-0.15. Based on the distribution chart, Bactiguard Holding AB ranks #77 out of 690 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bactiguard Holding AB has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bactiguard Holding AB ranks #77 out of 690 companies for EBIT per Share. This places Bactiguard Holding AB in the top 11% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 9.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.50, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Bactiguard Holding AB and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bactiguard Holding AB's current EBIT per Share is kr-0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Bactiguard Holding AB (CHIX:BACTBS) has a current EBIT per Share of kr-0.15. The stock's GF Value™ is kr274.02, compared to a current price of kr128.60 — trading 53.1% below its estimated fair value. The current EBIT per Share is kr-0.15. Bactiguard Holding AB's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Bactiguard Holding AB (CHIX:BACTBS), the current EBIT per Share is kr-0.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bactiguard Holding AB (CHIX:BACTBS) Overvalued in 2026?
Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued.
The current stock price of kr128.60 is trading 53.1% below its estimated GF Value™ of kr274.02.
Key valuation signals for CHIX:BACTBS:
EBIT per Share: kr-0.15
GF Value™: kr274.02 vs. price of kr128.60 (53.1% below fair value)
No single metric tells the full story. See the CHIX:BACTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
59GF Score
Get the complete analysis for CHIX:BACTBS
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BACTBS has been successfully added to your 
